A 2019 longitudinal study found that the rate of change in serum NfL levels served as a predictor for presymptomatic AD but that absolute NfL levels were observed to indicate the symptomatic phase and progression of AD10. The gene discussed is NEFL; the disease is Alzheimer disease.